Market Research Report Store Vaginal Atrophy (Atrophic Vaginitis)-API Insights, | Page 2

The report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources
information and data has been collected from various printable and non-printable sources like search
engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade
associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.
Scope
• A snapshot of the global Market therapeutics scenario for Vaginal Atrophy (Atrophic Vaginitis).
• A review of the marketed products under prescription for Vaginal Atrophy (Atrophic Vaginitis),
regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across
the globe.
• Product profiles for marketed products for
Vaginal Atrophy (Atrophic Vaginitis) with complete
description of mechanism of action, therapeutic class, target, route(s) of administration and chemical
details.
• Coverage of API Manufacturers for
Vaginal Atrophy (Atrophic Vaginitis) drugs in the United
States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for
Vaginal Atrophy (Atrophic Vaginitis) drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016.Reasons to Buy
• Evaluate the marketing status and exclusivity details of
Vaginal Atrophy (Atrophic Vaginitis) key
products to exploit opportunities for generic drug development opportunities.
• Key players in the pharmaceutical industry.
•Strategic drivers and restraints of this market are revealed and market opportunities and challenges are
identified.